16-2039907-C-CCAGAGCCATGCGGCCAT
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_002528.7(NTHL1):c.915_*16dupATGGCCGCATGGCTCTG variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002528.7 3_prime_UTR
Scores
Clinical Significance
Conservation
Publications
- familial adenomatous polyposis 3Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
- NTHL1-deficiency tumor predisposition syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- breast cancerInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
- meningiomaInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NTHL1 | NM_002528.7 | c.915_*16dupATGGCCGCATGGCTCTG | 3_prime_UTR_variant | Exon 6 of 6 | ENST00000651570.2 | NP_002519.2 | ||
NTHL1 | NM_001318193.2 | c.744_*16dupATGGCCGCATGGCTCTG | 3_prime_UTR_variant | Exon 5 of 5 | NP_001305122.2 | |||
NTHL1 | NM_001318194.2 | c.585_*16dupATGGCCGCATGGCTCTG | 3_prime_UTR_variant | Exon 6 of 6 | NP_001305123.1 | |||
NTHL1 | XM_047434171.1 | c.636_*16dupATGGCCGCATGGCTCTG | 3_prime_UTR_variant | Exon 6 of 6 | XP_047290127.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:1
The c.939_*16dup17 variant results from a duplication of 17 nucleotides at positions c.939 to c.*16 at the 3' end of the NTHL1 gene. This nucleotide region is generally well conserved in available vertebrate species. Based on the available evidence, the clinical significance of this variant remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at